STAT signalling in the heart and cardioprotection
Surinder M Soond1, David S Latchman, Anastasis Stephanou
1Institute of Child Health, University College London, London, WC1N 1EH, UK. s.soond@ich.ucl.ac.uk
Insights
Signal transducers and activators of transcription (STATs) are key in cardiac myocyte survival after heart attacks. Understanding STATs offers new therapeutic targets for heart injury.
Area of Science:
- Cardiovascular Biology
- Molecular Signaling
- Cellular Fate Determination
Background:
- Ischaemia-reperfusion (IR) injury significantly impacts myocardial infarction severity.
- Cellular and molecular pathways governing cardiac myocyte fate post-IR are under intense investigation.
- The STAT family of proteins plays a crucial role in mediating cellular responses to IR.
Purpose of the Study:
- To review recent advancements in understanding STAT protein regulation and function in cardioprotective signaling.
- To elucidate the role of STATs in myocardial preconditioning and IR injury.
- To explore therapeutic potential targeting STAT signaling for cardiac myocyte survival.
Main Methods:
- Literature review focusing on recent research (past six years).
- Analysis of signaling pathways involving Janus kinases (JAKs) and STATs.
- Examination of gene expression regulation (pro-survival and apoptotic) by STATs.
Main Results:
- STATs are inducibly activated by JAKs during IR.
- STATs transcriptionally regulate genes involved in cell survival and apoptosis.
- STAT signaling is implicated in both cardioprotective preconditioning and IR injury.
Conclusions:
- STAT proteins are critical mediators of cardiac myocyte response to IR.
- Targeting STAT signaling pathways presents a promising therapeutic strategy for mitigating IR-induced myocardial damage.
- Further research into STAT regulation can lead to novel interventions for heart protection.
Abstract:
During the past six years, great progress has been made in defining the key cellular and molecular signalling pathways that determine the fate of cardiac myocytes after ischaemia-reperfusion (IR) and consequently the severity of myocardial infarction. Among the complex network of kinases and transcription factors that mediate signals during IR is the STAT family of 'signal transducers and activators of transcription'. During IR they are inducibly activated by Janus kinases and have the capability of transcriptionally regulating pro-survival and apoptotic gene expression. In this review we focus on recent progress made in elucidating the regulation and role of the STAT family of proteins during cardioprotective signalling events in myocardial preconditioning and during IR injury in cardiac myocyte cells and the myocardium. Moreover, we also highlight developments in understanding how this signalling pathway might be amenable to therapeutic intervention, permitting cardiac myocyte survival following IR.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Paracrine Signaling
Heart Failure II: Pathophysiology

